Isoray posts positive 2007 year-end financial results
Medical isotope company Isoray of Richland, Wash., reported that gross losses were down amongst product sales increases for its financial results for the quarter and year, which ended on June 30.

The gross loss for Q4-FY2007 was $7,372, an improvement of 99 percent over the gross loss of $569,306 for Q4-FY2006. Gross loss for the fiscal year, which ended June 30 was $54,597, which represents an improvement of 97 percent over the fiscal year’s gross loss of $1.8 million.

Product sales increased by 188 percent to $5.7 million over fiscal year 2006, highlighted by a fourth quarter product sales increase of 102 percent to $1.65 million.